Part 1: In-vitro release of gentamicinpalmitate coating in uncemented titanium implants
by Klaus-Dieter Kuhn
International Journal of Nano and Biomaterials (IJNBM), Vol. 3, No. 1, 2010

Abstract: Microporous surfaces of commercially available uncemented Tilastan® implants were coated with gentamicinpalmitate. The roughness of the titanium implant surfaces remained largely intact. During the first few days, the gentamicin release was comparable to the elution of this antibiotic from commercially available PMMA bone cements. Compared to PMMA cements, the implants coated with the gentamicinpalmitate completely released the gentamicin within the first five to eight days. Both uncemented implants with a gentamicinpalmitate coating and gentamicin containing bone cements used with cemented implants sustainably reduce the infection risk. It can be hypothesised that these in-vitro results are transferrable to the well documented clinical findings of antibiotic loaded cemented arthroplasty, and can therefore potentially provide a significant contribution to the reduction of infection in the use of uncemented prostheses.

Online publication date: Tue, 19-Oct-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nano and Biomaterials (IJNBM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com